Development and application of an elastic net logistic regression model to investigate the impact of cardiac substructure dose on radiation-induced pericardial effusion in patients with NSCLC

References

• Gagliardi G, Constine LS, Moiseenko V, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S77–S85.
   PubMed Web of Science ®Google Scholar
• Osawa S, Yamada T, Saitoh T, et al. Treatment with corticosteroid for pericardial effusion in a patient with advanced synchronous esophageal and gastric cancers following chemoradiotherapy. Case Rep Gastroenterol. 2010;4(2):229–237.
   PubMedGoogle Scholar
• Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16(2):187–199.
   PubMed Web of Science ®Google Scholar
• Wang K, Eblan MJ, Deal AM, et al. Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. JCO. 2017;35(13):1387–1394.
   PubMed Web of Science ®Google Scholar
• He L, Chapple A, Liao ZX, et al. Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer. Radiother Oncol. 2016;121(1):70–74.
   PubMed Web of Science ®Google Scholar
• Ning MS, Tang L, Gomez DR, et al. Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;99(1):70–79.
   PubMed Web of Science ®Google Scholar
• Cella L, Liuzzi R, Conson M, et al. Multivariate normal tissue complication probability modelling of heart valve dysfunction in Hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys. 2013;87(2):304–310.
   PubMed Web of Science ®Google Scholar
• Moignier A, Broggio D, Derreumaux S, et al. Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: a study based on patient specific artery segments dose calculation. Radiother Oncol. 2015;117(3):467–472.
   PubMed Web of Science ®Google Scholar
• Correa CR, Litt HI, Hwang WT, et al. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol. 2007;25(21):3031–3037.
   PubMed Web of Science ®Google Scholar
• Nilsson G, Holmberg L, Garmo H, et al. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol. 2012;30(4):380–386.
   PubMed Web of Science ®Google Scholar
• Correa CR, Das IJ, Litt HI, et al. Association between tangential beam treatment parameters and cardiac abnormalities after definitive radiation treatment for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2008;72(2):508–516.
   PubMed Web of Science ®Google Scholar
• Liao Z, Lee JJ, Komaki R, et al. Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer. J Clin Oncol. 2018;36(18):1813–1822.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common terminology criteria for adverse events v4.0 (NIH publication #09e7473). Bethesda, MD: National Cancer Institute, National Institutes of Health, US Department of Health and Human Services; 2009.
   Google Scholar
• Shiraishi Y, Xu C, Yang J, et al. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or intensity-modulated radiation therapy. Radiother Oncol. 2017;125(1):48–54.
   PubMed Web of Science ®Google Scholar
• Yang J, Amini A, Williamson R, et al. Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy. Pract Radiat Oncol. 2013;3(4):e139–e147.
   PubMedGoogle Scholar
• Zou H, Hastie T. Regularization and variable selection via the elastic net. J Royal Statistical Soc B. 2005;67(2):301–320.
   Google Scholar
• Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. 2nd ed. New York, NY: Springer; 2009.
   Google Scholar
• Niedzielski JS, Yang J, Liao Z, et al. 18F-Fluorodeoxyglucose positron emission tomography can quantify and predict esophageal injury during radiation therapy. Int J Radiat Oncol Biol Phys. 2016;96(3):670–678.
   PubMed Web of Science ®Google Scholar
• Dean JA, Wong KH, Welsh LC, et al. Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy. Radiother Oncol. 2016;120(1):21–27.
   PubMed Web of Science ®Google Scholar
• Dean JA, Wong K, Gay H, et al. Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy. Clin Transl Radiat Oncol. 2018;8:27–39.
   PubMed Web of Science ®Google Scholar
• Tibshirani R. Regression shrinkage and selection via the lasso. J R Statist Soc B. 1996;58(1):267–288.
   Google Scholar
• Niedzielski JS, Yang J, Stingo F, et al. A novel methodology using CT imaging biomarkers to quantify radiation sensitivity in the esophagus with application to clinical trials. Sci Rep. 2017;7(1):6034
   PubMed Web of Science ®Google Scholar
• Deist TM, Dankers F, Valdes G, et al. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: an empirical comparison of classifiers. Med Phys. 2018;45(7):3449–3459.
   PubMed Web of Science ®Google Scholar
• Xu CJ, van der Schaaf A, Schilstra C, et al. Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models. Int J Radiat Oncol Biol Phys. 2012;82(4):e677–e684.
   PubMed Web of Science ®Google Scholar
• Wang K, Pearlstein KA, Patchett ND, et al. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer. Radiother Oncol. 2017;125(2):293–300.
   PubMed Web of Science ®Google Scholar
• Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186–1197.
   PubMed Web of Science ®Google Scholar